ArticleJournal of hematology & oncology2018

Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer.

Bowen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.